Canada Clinical Trial Supplies Market Size & Outlook

The clinical trial supplies market in Canada is expected to reach a projected revenue of US$ 100.6 million by 2030. A compound annual growth rate of 4.6% is expected of Canada clinical trial supplies market from 2024 to 2030.
Revenue, 2023 (US$M)
$73.2
Forecast, 2030 (US$M)
$100.6
CAGR, 2024 - 2030
4.6%
Report Coverage
Canada

Canada clinical trial supplies market, 2018-2030 (US$M)

Canada

Canada clinical trial supplies market highlights

  • The Canada clinical trial supplies market generated a revenue of USD 73.2 million in 2023 and is expected to reach USD 100.6 million by 2030.
  • The Canada market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.


Clinical trial supplies market data book summary

Market revenue in 2023USD 73.2 million
Market revenue in 2030USD 100.6 million
Growth rate4.6% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III
Key market players worldwideAlmac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair


Other key industry trends

  • In terms of revenue, Canada accounted for 2.8% of the global clinical trial supplies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 2,105.8 million by 2030.

Phase iii was the largest segment with a revenue share of 52.32% in 2023. Horizon Databook has segmented the Canada clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.


Canada accounts for 4.0% of the total number of clinical trials and stands fourth in terms of clinical trial sites. Presence of an advanced health & education system, government support, and presence of a diverse population are among the main factors driving the growth of clinical trial supplies market.

Major biopharmaceutical companies conduct clinical trials in Canada, which makes the country a lucrative market for players operating in clinical trial supplies market. These factors are expected to drive growth of clinical trial supplies market in the country.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Supplies Market Companies

Name Profile # Employees HQ Website

Canada clinical trial supplies market size, by phase, 2018-2030 (US$M)

Canada Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)

Canada clinical trial supplies market size, by phase, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more